Overview

We study genetic and molecular drivers of cancer and therapy resistance to identify and validate novel therapeutic targets and advance precision oncology for Saudi patients.

Improving Treatment Strategies for Thyroid Cancer

Papillary thyroid cancer is the second commonest malignancy affecting Saudi women after breast cancer, with up to a quarter of patients suffering from aggressive disease, leading to treatment resistance and poor outcomes. Our team is characterizing the genetic and molecular components that underlie aggressive papillary thyroid cancer with the aim of identifying biomarkers and new therapies.

Our Team

Our strength lies in collaboration and innovation.
Pratheeshkumar Poyil - 1510229
Pratheeshkumar Poyil
Associate Scientist / Team Leader
Beta Version